pharmaceutical-research

NOCTURNAL: Exploring the dark chemical space. A streamlined computational drug discovery platform from target identification to optimized drug visualization. Featuring a unique molecular optimization algorithm "MutaGen" and an interactive chemical space visualization module "ChemNet". All reinforced behind a modular, fault-tolerant architecture.

A GNN-based platform for predicting novel drug-target interactions to accelerate R&D.

Initial release: Upadacitinib topical formulation verification (SEP-01 to EXP-03)

Computational medicinal chemistry project integrating molecular docking, network pharmacology, and ADMET prediction to evaluate berberine as a potential therapeutic candidate against Type 2 Diabetes Mellitus.

Streamline pharmaceutical research & clinical trials with a customizable Notion template

PharmaDiscover, featuring a MoleculeSimulator application. It includes Razor pages, controllers, services, models, and database files, suggesting it is a web app with simulation and data processing capabilities.

XtalPi is an AI-and-quantum-physics drug discovery and materials research platform company with headquarters in Cambridge, Massachusetts and major operations in Beijing, Shanghai, and Shenzhen, publicly listed on the Hong Kong Stock Exchange under stock code 2228.HK.